Clinical trials
Diabetes Mellitus, Type 2 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 11 |
| 2009 | 11 |
| 2010 | 15 |
| 2011 | 9 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 112 |
| Recruiting | 13 |
| Terminated | 13 |
| Active, not recruiting | 6 |
| Unknown status | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 25 |
| AstraZeneca | 15 |
| Boehringer Ingelheim | 13 |
| Eli Lilly and Company | 10 |
| Sanofi | 6 |
| Bayer | 5 |
| GlaxoSmithKline | 5 |
| Janssen Research & Development, LLC | 5 |
| Novartis Pharmaceuticals | 5 |
| Hasselt University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 148 |
| Diabetes Mellitus | 40 |
| Diabetes Mellitus, Type 1 | 7 |
| Obesity | 7 |
| Renal Insufficiency, Chronic | 7 |
| Cardiovascular Diseases | 5 |
| Coronary Artery Disease | 4 |
| Diabetic Nephropathies | 4 |
| Glucose Metabolism Disorders | 4 |
| Heart Failure | 4 |
Trials
Showing 26 to 50 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.